$Ligand Pharmaceuticals (LGND.US)$Revenue has generally grow...

$Ligand Pharmaceuticals (LGND.US)$Revenue has generally grown over the past 5 years, reaching a peak of 0.25 billion in 2018 before sliding by 52% to 0.12 billion in 2019, then continuously growing for 2 years to reach 0.277 billion. Operating profit reached its peak of 0.164 billion in 2018, remained relatively stable in 2019 and 2020, dropped to 0.079 billion in 2021, while net income in 2018 reached 0.63 billion due to a gain from the sale of fixed assets, remained stable in 2020, and reached 0.057 billion in 2021.